Results
1
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
1 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨93.3b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨293.09
7D
-12.6%
1Y
-25.4%